Reflections on Status Quo and Development Pathways of Traditional Chinese Medicine Technology Transfer in Context of Digital-intelligent Transformation
10.13422/j.cnki.syfjx.20251239
- VernacularTitle:数智化转型视域下的中医药技术转移现状与发展路径思考
- Author:
Jie ZHANG
1
;
Jing XU
2
;
Guangwei ZHENG
1
;
Huayu ZHANG
1
;
Chang LIU
1
;
Xiaoxiao WEN
1
;
Xishui PAN
1
;
Bin WANG
1
Author Information
1. Technology Cooperation Center of Traditional Chinese Medicine， China Academy of Chinese Medical Sciences， Beijing 100700， China
2. Beijing Information Science and Technology University， Beijing 102206， China
- Publication Type:Journal Article
- Keywords:
traditional Chinese medicine（TCM）;
digital-intelligent TCM;
technology transfer;
scientific and technological achievements;
achievement evaluation
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2026;32(4):235-240
- CountryChina
- Language:Chinese
-
Abstract:
As a distinctive resource of Chinese civilization， traditional Chinese medicine （TCM） technology transfer faces significant opportunities under the background of digital and intelligent transformation， while also being constrained by unique challenges such as the complexity of its theoretical system， lengthy industrial chains， and multidimensional policy restrictions， resulting in a "high-value-high-threshold" paradox. At present， TCM technology transfer is deeply trapped in a "threefold reluctance" dilemma， i.e.， unwillingness to transfer， inability to transfer， and lack of capacity to transfer. Specifically， the disconnection between scientific research evaluation systems and market demand leads to low conversion rates of research achievements， unclear ownership and compliance risks suppress innovation incentives， and the absence of professional services intensifies supply-demand mismatches. This article systematically analyzes the specific characteristics of TCM technology transfer and proposes a breakthrough pathway centered on full-chain digital and intelligent transformation. By integrating technologies such as intelligent sorting systems， blockchain-based traceability， and AI diagnostic models， the TCM ecosystem spanning "cultivation-production-service" can be reconstructed. In terms of standardization， promoting the progression from "experience-based data conversion" to "data standardization" and further to "intelligent standardization" is advocated to resolve quality control challenges. For example， a "three-no-one-full" certification system can strengthen quality trust. Policy coordination should focus on optimizing mechanisms for the transformation of scientific and technological achievements， while exploring intellectual property securitization and risk-sharing models to stimulate research momentum. In terms of internationalization， reliance on the Belt and Road Initiative platform to promote the export of geo-authentic medicinal material brands and standards is recommended to build a dual-driven model of "technology plus culture". Looking ahead， through the construction of national-level databases， the cultivation of interdisciplinary talent， and the mutual recognition of international standards， a new paradigm of "scientific intelligent manufacturing" can be formed， providing systematic solutions for the modernization of TCM and global health governance.
